Clinical trial
Telmisartan and Flow-Mediated Dilatation in Older HIV-Infected Patients at Risk for Cardiovascular Disease
NCT01578772 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Telmisartan and Flow-Mediated Dilatation in Older HIV-Infected Patients at Risk for Cardiovascular Disease
- Lead sponsor
- University of California, Los Angeles
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- August 31, 2012
- Completion date
- March 31, 2013
- Enrollment
- 17 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
endothelial dysfunction